Search Results - Sebastiano Buti

Refine Results
  1. 1

    Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review by Giulia Mazzaschi, Federico Quaini, Sebastiano Buti

    Get full text
    Article


  2. 2

    The interplay between cholesterol (and other metabolic conditions) and immune-checkpoint immunotherapy: shifting the concept from the “inflamed tumor” to the “inflamed patient”... by Melissa Bersanelli, Alessio Cortellini, Sebastiano Buti

    Published in Human Vaccines & Immunotherapeutics (2021-07-01)
    Get full text
    Article


  3. 3

    Immune checkpoint inhibitors in adjuvant setting after radical resection of melanoma: a meta-analysis of the pivotal trials by Melissa Bersanelli, Fausto Petrelli, Sebastiano Buti, Ignazio Stanganelli

    Published in Human Vaccines & Immunotherapeutics (2022-05-01)
    Get full text
    Article


  4. 4

    Systemic adjuvant therapies in renal cell carcinoma by Sebastiano Buti, Melissa Bersanelli, Maddalena Donini, Andrea Ardizzoni

    Published in Oncology Reviews (2012-10-01)
    Get full text
    Article


  5. 5

    Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of “palateau” by Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, Pasquale Rescigno, Giuseppe Luigi Banna, Sebastiano Buti

    Published in Human Vaccines & Immunotherapeutics (2024-12-01)
    Get full text
    Article


  6. 6

    Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism? by Giandomenico Roviello, Sebastiano Buti, Carlo Cattrini, Alessia Mennitto, Carlo Messina, Chiara Airoldi, Gianmarco Vannini, Melissa Bersanelli

    Published in Therapeutic Advances in Urology (2021-07-01)
    Get full text
    Article


  7. 7

    Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer an... by Tappei Takada, Yukari Uemura, Haruki Kume, Sebastiano Buti, Satoru Taguchi, Taketo Kawai, Katsuhiko Nara, Takehito Yamamoto

    Published in Journal for ImmunoTherapy of Cancer (2024-03-01)
    Get full text
    Article


  8. 8

    Concomitant antihypertensive medication and outcome of patients with metastatic castration‐resistant prostate cancer receiving enzalutamide or abiraterone acetate by Ondřej Fiala, Petr Hošek, Hana Korunková, Milan Hora, Jiří Kolář, Ondřej Šorejs, Ondřej Topolčan, Jan Filipovský, Václav Liška, Matteo Santoni, Sebastiano Buti, Jindřich Fínek

    Published in Cancer Medicine (2024-01-01)
    Get full text
    Article


  9. 9

    Percutaneous Ablation of T1 Renal Masses: Comparative Local Control and Complications after Radiofrequency and Cryoablation by Lorenzo Bertolotti, Federica Segato, Francesco Pagnini, Sebastiano Buti, Andrea Casarin, Antonio Celia, Francesco Ziglioli, Umberto Maestroni, Giuseppe Pedrazzi, Velio Ascenti, Chiara Martini, Calogero Cicero, Massimo De Filippo

    Published in Diagnostics (2023-09-01)
    Get full text
    Article


  10. 10

    Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma by Martina Catalano, Ugo De Giorgi, Marco Maruzzo, Davide Bimbatti, Sebastiano Buti, Giulia Mazzaschi, Giuseppe Procopio, Matteo Santoni, Luca Galli, Raffaele Conca, Laura Doni, Lorenzo Antonuzzo, Giandomenico Roviello

    Published in Biomedicines (2022-09-01)
    Get full text
    Article


  11. 11

    External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell Carcinoma by Michele Maffezzoli MD, Alessio Signori MD, Davide Campobasso MD, Giulia Claire Giudice MD, Nicola Simoni MD, Massimo De Filippo MD, Enrico Maria Silini MD, Sebastiano Buti MD, PhD

    Published in Technology in Cancer Research & Treatment (2025-03-01)
    Get full text
    Article


  12. 12

    The Role of CT Imaging in Characterization of Small Renal Masses by Maria Vittoria Bazzocchi, Carlotta Zilioli, Vita Ida Gallone, Claudia Commisso, Lorenzo Bertolotti, Francesco Pagnini, Francesco Ziglioli, Umberto Maestroni, Alberto Aliprandi, Sebastiano Buti, Giuseppe Procopio, Giorgio Ascenti, Chiara Martini, Massimo De Filippo

    Published in Diagnostics (2023-01-01)
    Get full text
    Article


  13. 13

    The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab by Giulia Claire Giudice, Sara Elena Rebuzzi, Giulia Mazzaschi, Federica Pecci, Michele Maffezzoli, Alessandro Acunzo, Letizia Gnetti, Enrico Maria Silini, Giuseppe Caruso, Elena Rapacchi, Pasquale Rescigno, Giuseppe Fornarini, Giuseppe Luigi Banna, Sebastiano Buti

    Get full text
    Article


  14. 14

    International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study) by Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, Sebastiano Buti, Giuseppe Procopio, Ugo De Giorgi, Sandro Pignata, Emanuele Naglieri, Marco Maruzzo, Giuseppe Luigi Banna, Pasquale Rescigno, Carlo Messina, Alvise Mattana, Umberto Basso, Davide Bimbatti

    Published in BMC Cancer (2024-06-01)
    Get full text
    Article


  15. 15

    Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario by Giulia Mazzaschi MD, Giulia Claire Giudice MD, Matilde Corianò MD, Davide Campobasso MD, Fabiana Perrone MD, Michele Maffezzoli MD, Irene Testi MD, Luca Isella MD, Umberto Maestroni MD, Sebastiano Buti MD, PhD

    Published in Technology in Cancer Research & Treatment (2023-03-01)
    Get full text
    Article


  16. 16

    Combined standard immunosuppression and immune checkpoint inhibition for BKPyV+ metastatic renal cell carcinoma of the graft in a kidney transplant recipient with chronic rejection... by Ilaria Gandolfini, Martina Manini, Giuseppe Daniele Benigno, Micaela Gentile, Alessandra Palmisano, Danio Somenzi, Letizia Gnetti, Marco Delsante, Benedetta Mordà, Marta D’Angelo, Daniel Salvetti, Enrico Fiaccadori, Enrico Fiaccadori, Sebastiano Buti, Umberto Maggiore, Umberto Maggiore

    Published in Frontiers in Oncology (2025-03-01)
    Get full text
    Article


  17. 17

    Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses... by Melissa Bersanelli, Letizia Gnetti, Francesco Paolo Pilato, Elena Varotti, Federico Quaini, Nicoletta Campanini, Elena Rapacchi, Roberta Camisa, Paolo Carbognani, Enrico Maria Silini, Michele Rusca, Francesco Leonardi, Umberto Maestroni, Mimma Rizzo, Matteo Brunelli, Sebastiano Buti, Luca Ampollini

    Published in Exploration of Targeted Anti-tumor Therapy (2023-08-01)
    Get full text
    Article


  18. 18

    Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study by Martina Catalano, Sara Elena Rebuzzi, Sara Elena Rebuzzi, Marco Maruzzo, Ugo De Giorgi, Sebastiano Buti, Sebastiano Buti, Luca Galli, Giuseppe Fornarini, Paolo Andrea Zucali, Paolo Andrea Zucali, Melanie Claps, Silvia Chiellino, Ilaria Zampiva, Stefania Pipitone, Riccardo Ricotta, Mariella Sorarù, Veronica Mollica, Marianna Tudini, Lucia Fratino, Veronica Prati, Orazio Caffo, Francesco Atzori, Franco Morelli, Giuseppe Prati, Franco Nolè, Francesca Vignani, Alessia Cavo, Marilena Di Napoli, Andrea Malgeri, Emanuele Naglieri, Alessio Signori, Giuseppe Luigi Banna, Pasquale Rescigno, Linda Cerbone, Lorenzo Antonuzzo, Lorenzo Antonuzzo, Giandomenico Roviello

    Published in Frontiers in Immunology (2024-07-01)
    Get full text
    Article


  19. 19

    The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospect... by Chiara Tommasi, Giulia Scartabellati, Diana Giannarelli, Ugo De Giorgi, Nicole Brighi, Giuseppe Fornarini, Sara Elena Rebuzzi, Silvia Puglisi, Orazio Caffo, Stefania Kinspergher, Alessia Mennitto, Carlo Cattrini, Matteo Santoni, Elena Verzoni, Alessandro Rametta, Marco Stellato, Andrea Malgeri, Giandomenico Roviello, Matteo Brunelli, Sebastiano Buti

    Published in Therapeutic Advances in Urology (2023-07-01)
    Get full text
    Article


  20. 20

    Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study by Lucia Fratino, Jerry Polesel, Emilio Francesco Giunta, Marco Maruzzo, Sebastiano Buti, Mona Ali Hassan, Umberto Basso, Sara Elena Rebuzzi, Ugo De Giorgi, Marika Cinausero, Helga Lipari, Teresa Gamba, Davide Bimbatti, Arianna Dri, Paola Ermacora, Francesca Vignani, Giuseppe Fornarini, Pasquale Rescigno, Giuseppe Luigi Banna

    Published in Scientific Reports (2024-02-01)
    Get full text
    Article


Search Tools: